Industry: Pharmaceuticals, Biotechnology
LipidViro Tech, Inc. is an early-stage biotechnology company engaged in research and commercial development of two primary platforms: d -OSAB Therapy, a treatment targeting cardiovascular disease and stroke; and PathPure, a purification process for production of pathogen-free biologics. During mid-2006 LipidViro is scheduled to commence a 100 patient Phase IIa study, treating patients who have suffered an ischemic brain stroke with LipidViro d -OSAB Therapy. LipidViro PathPure, is a purification process for production of pathogen-free biologics. Biologics include animal and human-derived blood, plasma, sera, proteins, and cell ( www.lipidviro.com )
Lipidviro Tech Inc
1338 South Foothill Drive #126
Salt Lake City, Utah 84108
USA
Tel: (801) 583-9900